Enveric Biosciences Inc vs Global X Lithium & Battery Tech ETF — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Global X Lithium & Battery Tech ETF trades at $69.2. The key difference: Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | LIT | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $17.40 | $91.62 |
52-Week Low | $1.28 | $39.73 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LIT trades at $69.44, down 2.99% in the last session amid a bearish technical signal. The stock faces selling pressure with moving averages indicating a downtrend, though oversold RSI readings suggest potential for a near-term bounce. Recent news highlights strong catalysts from the electric vehicle, energy storage, and semiconductor sectors, with the ETF having doubled over the past year according to Seeking Alpha on 2026-07-06.
Outlook remains tied to lithium market dynamics and EV adoption trends, offering growth exposure but with volatility risks from Chinese export policies and competitive pressures. The absence of key valuation ratios in the data necessitates deeper fundamental review for investment decisions.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →